Supriya Lifescience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

248.48

165.69

123.49

207.25

167.31

Net cashflow-operating activity

164.68

113.31

66.19

48.80

78.91

Net cash used in investing activity

-152.24

-173.58

-133.15

-59.82

-46.80

Netcash used in fin. activity

-8.23

-22.36

-3.37

149.65

-14.52

Net inc/dec in cash and equivlnt

4.20

-82.63

-70.33

138.63

17.59

Cash and equivalnt begin of year

74.96

157.58

227.91

89.28

74.71

Cash and equivalnt end of year

79.15

74.96

157.58

227.91

92.29